Kazia Therapeutics Limited
Kazia Therapeutics Limited (KZIA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · KZIA · as of Jun 8, 2026
Key Statistics
Explore Kazia Therapeutics Limited Data
kzia stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
The KZIA analyst consensus is Buy, based on ratings from 2 Wall Street analysts over the past 3 months. The average 12-month price target is $21.50, representing +88.60% upside from the current price of $11.40.
Competitors & Peers
kzia competitorsKZIA
BDRX
CANF
CMND
CNSP
GRIStock Performance
Full HistoryAbout Kazia Therapeutics Limited
Kazia Therapeutics Limited is a biotechnology firm primarily dedicated to creating pharmaceutical treatments for cancer. Its leading therapeutic asset is Paxalisib, a distinctive small molecule that c…
what is kazia therapeutics limited · kzia stock overview · kazia therapeutics limited company profile · who is kazia therapeutics limited ceo · kzia NASDAQ · kazia therapeutics limited headquarters · kazia therapeutics limited business segments
About Stock Overview & Key Data
Kazia Therapeutics Limited (KZIA) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 6, 1999. As of the latest trading session, KZIA stock price is $11.40, with a market capitalization of $18.5M. The stock has returned +115.09% over the past 12 months and +65.46% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Kazia Therapeutics Limited stock is Buy, with an average 12-month price target of $21.50. In fiscal year 2025, Kazia Therapeutics Limited reported revenue of $42000.00 and net income of -$20.7M. For detailed data — including Kazia Therapeutics Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Kazia Therapeutics Limited (KZIA) stock price is $11.40. The stock is traded on NASDAQ under the ticker symbol KZIA. The 52-week range is $4.86 – $17.40.